UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback